Skip to main content

Advertisement

Table 2 Treatment characteristics

From: Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term results

RT according to protocol no. (%) 111 (94.1)
Interval between end of RT and surgery median/range (days) 3/3 - 10
Type of surgery no. (%)  
LAR 81 (68.6)
APR 35 (29.7)
Local excision 1 (0.8)
No surgery 1 (0.8)
Protective stoma after LAR 72 (87.8)
Pathological tumor stage no. (%)  
pT1 8 (6.8)
pT2 34 (28.8)
pT3 74 (62.7)
pT4 1 (0.8)
Pathological nodal stage no. (%)  
Node negative 64 (54.2)
Node positive 53 (44.9)
Pathological UICC stage no. (%)  
I 32 (27.1)
II 30 (25.4)
III 44 (37.3)
IV 11 (9.3)
Resection status no. (%)  
R0 104 (88.1)
R1 (all local) 6 (5.1)
R2 (all systemic) 4 (3.4)
Unknown 3 (2.5)
Number of removed lymph nodes Median/range 12/1-30
Indication for chemotherapy no. (%) 81 (68.6)
Actually performed chemotherapy no. (%) 61 (75.3)
5-FU & LV chemotherapy 35 (57.4)
FOLFOX4 15 (24.6)
others 11 (18)
  1. RT (radiotherapy); LAR (low anterior resection); APR (abdominoperineal resection);